{"id":203230,"date":"2025-01-07T06:04:53","date_gmt":"2025-01-07T12:04:53","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2025\/01\/new-ai-tool-uses-routine-blood-tests-to-predict-immunotherapy-response-for-many-cancers"},"modified":"2025-01-07T06:04:53","modified_gmt":"2025-01-07T12:04:53","slug":"new-ai-tool-uses-routine-blood-tests-to-predict-immunotherapy-response-for-many-cancers","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2025\/01\/new-ai-tool-uses-routine-blood-tests-to-predict-immunotherapy-response-for-many-cancers","title":{"rendered":"New AI tool uses routine blood tests to predict immunotherapy response for many cancers"},"content":{"rendered":"<p><a class=\"aligncenter blog-photo\" href=\"https:\/\/lifeboat.com\/blog.images\/new-ai-tool-uses-routine-blood-tests-to-predict-immunotherapy-response-for-many-cancers2.jpg\"><\/a><\/p>\n<p>Doctors around the world may soon have access to a new tool that could better predict whether individual cancer patients will benefit from immune checkpoint inhibitors\u2014a type of immunotherapy\u2014using only routine blood tests and clinical data.<\/p>\n<p>The artificial intelligence\u2013based model, dubbed SCORPIO, was developed by a team of researchers from Memorial Sloan Kettering Cancer Center (MSK) and the Tisch Cancer Institute at Mount Sinai.<\/p>\n<p>The model is not only cheaper and more accessible, it\u2019s significantly better at predicting outcomes than the two current biomarkers approved by the U.S. Food and Drug Administration (FDA), according to findings <a href=\"https:\/\/www.nature.com\/articles\/s41591-024-03398-5\" target=\"_blank\">published<\/a> in Nature Medicine.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Doctors around the world may soon have access to a new tool that could better predict whether individual cancer patients will benefit from immune checkpoint inhibitors\u2014a type of immunotherapy\u2014using only routine blood tests and clinical data. The artificial intelligence\u2013based model, dubbed SCORPIO, was developed by a team of researchers from Memorial Sloan Kettering Cancer Center [\u2026]<\/p>\n","protected":false},"author":391,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11,6],"tags":[],"class_list":["post-203230","post","type-post","status-publish","format-standard","hentry","category-biotech-medical","category-robotics-ai"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/203230","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/391"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=203230"}],"version-history":[{"count":0,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/203230\/revisions"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=203230"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=203230"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=203230"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}